Summary Review - Food and Drug Administration · 2011. 6. 8. · (b) (4) SIGNATURES PAGE Patricia...
36
CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 125377Orig1s000 SUMMARY REVIEW
Transcript of Summary Review - Food and Drug Administration · 2011. 6. 8. · (b) (4) SIGNATURES PAGE Patricia...
-
CENTER FOR DRUG EVALUATION AND RESEARCH
APPLICATION NUMBER:
125377Orig1s000
SUMMARY REVIEW
-
(b) (4) (b) (4)
(b) (4)
(b) (4)
(b) (4)
-
(b) (4)
(b) (4)
-
(b) (4)
-
(b) (4)
-
(b) (4)
(b) (4)
-
(b) (4)
-
(b) (4)
-
(b) (4)
-
(b) (4)
(b) (4)
-
(b) (4)
-
(b) (4)
(b) (4)
(b) (4)
(b) (4)
(b) (4)
(b) (4)
(b) (4)
-
(b) (4)
(b) (4)
(b) (4)
(b) (4)
(b) (4)
-
(b) (4)
(b) (4)
(b) (4)
-
SIGNATURES PAGE
Patricia Keegan, M.D./s/Patricia Keegan, M.D.Director, Division of Biologic
Oncology ProductsOffce of Oncology Drug Products
STN BL 125377/0 Division Director Summary Review
March 12, 2011Date
Page 31 of3l